[Pharmacotherapy in chronic Heart Failure]

MMW Fortschr Med. 2017 Aug;159(14):42-48. doi: 10.1007/s15006-017-9590-9.
[Article in German]
No abstract available

Keywords: ARNI; HFmrEF; HFpEF; HFrEF; Heart failure; pharmacotherapy.

Publication types

  • Review

MeSH terms

  • Age Factors
  • Cardiotonic Agents / therapeutic use*
  • Chronic Disease
  • Disability Evaluation
  • Evidence-Based Medicine
  • Heart Failure / classification
  • Heart Failure / diagnosis
  • Heart Failure / drug therapy*
  • Heart Failure / mortality
  • Hospitalization
  • Humans
  • Pleural Effusion / classification
  • Pleural Effusion / diagnosis
  • Pleural Effusion / drug therapy
  • Pleural Effusion / mortality
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Survival Rate
  • Ventricular Dysfunction, Left / classification
  • Ventricular Dysfunction, Left / diagnosis
  • Ventricular Dysfunction, Left / drug therapy
  • Ventricular Dysfunction, Left / mortality

Substances

  • Cardiotonic Agents